No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Parnax Lab Limited specializes in the production and commercialization of a variety of pharmaceutical and healthcare products. Their offerings span a diverse range of medicinal forms, including liquid preparations, topical applications like ointments, gels, and creams, as well as solid oral dosages such as tablets and capsules. The enterprise was established on August 3, 1982, and operates from its corporate headquarters located in Mumbai, India.
www.naxparlab.comNo one on the platform currently holds PARNAXLAB.BO.
No tracked institution reports a position in PARNAXLAB.BO as of their last filing.
No one on the platform has traded PARNAXLAB.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PARNAXLAB.BOParnax Lab Limited | $121.45 | -2.06% | $1.4B | — |
| AUROLAB.BOAuro Laboratories Limited | $247.95 | +1.95% | $1.5B | — |
| BALPHARMA.NSBal Pharma Limited | $102.00 | -5.06% | $1.6B | — |
| CORALAB.BOCoral Laboratories Limited | $570.05 | +0.80% | $2.0B | — |
| DENISCHEM.BODenis Chem Lab Limited | $70.00 | -0.65% | $971M | — |
| KIMIABL.BOKimia Biosciences Ltd. | $27.60 | -2.82% | $1.3B | — |
| LACTOSE.BOLactose (India) Limited | $99.20 | +0.15% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry